Cargando…

Effectiveness of a combined strategy to improve therapeutic compliance and degree of control among patients with hypercholesterolaemia: a randomised clinical trial

BACKGROUND: In subjects with hypercholesterolaemia, cholesterol values remain above guideline levels. One of the limiting factors to the achievement of goals in such patients is therapeutic non-adherence. The aim of this study is to assess the effectiveness of an intervention designed to improve con...

Descripción completa

Detalles Bibliográficos
Autores principales: Párraga-Martínez, Ignacio, Rabanales-Sotos, Joseba, Lago-Deibe, Fernando, Téllez-Lapeira, Juan M, Escobar-Rabadán, Francisco, Villena-Ferrer, Alejandro, Blasco-Valle, Mariano, Ferreras-Amez, José M, Morena-Rayo, Susana, del Campo-del Campo, José M, Ayuso-Raya, Maria Candelaria, Pérez-Pascual, José J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361143/
https://www.ncbi.nlm.nih.gov/pubmed/25599690
http://dx.doi.org/10.1186/1471-2261-15-8
_version_ 1782361610656940032
author Párraga-Martínez, Ignacio
Rabanales-Sotos, Joseba
Lago-Deibe, Fernando
Téllez-Lapeira, Juan M
Escobar-Rabadán, Francisco
Villena-Ferrer, Alejandro
Blasco-Valle, Mariano
Ferreras-Amez, José M
Morena-Rayo, Susana
del Campo-del Campo, José M
Ayuso-Raya, Maria Candelaria
Pérez-Pascual, José J
author_facet Párraga-Martínez, Ignacio
Rabanales-Sotos, Joseba
Lago-Deibe, Fernando
Téllez-Lapeira, Juan M
Escobar-Rabadán, Francisco
Villena-Ferrer, Alejandro
Blasco-Valle, Mariano
Ferreras-Amez, José M
Morena-Rayo, Susana
del Campo-del Campo, José M
Ayuso-Raya, Maria Candelaria
Pérez-Pascual, José J
author_sort Párraga-Martínez, Ignacio
collection PubMed
description BACKGROUND: In subjects with hypercholesterolaemia, cholesterol values remain above guideline levels. One of the limiting factors to the achievement of goals in such patients is therapeutic non-adherence. The aim of this study is to assess the effectiveness of an intervention designed to improve control of hypercholesterolaemic patients, consisting of a combined strategy that would include the delivery of printed information, treatment-compliance check cards and the dispatch of text messages as complementary measures in support of the intervention at the general practitioner’s practice. METHODS/DESIGN: A randomised, parallel-group clinical trial will be conducted at the family medicine outpatient facilities of eight health centres in three of Spain’s Autonomous Regions (Comunidades Autónomas), covering a total of 358 subjects aged 18 years or over with diagnosis of hypercholesterolaemia. Patients in the intervention group will be supplied with printed material with information on the disease and its management, mobile-telephone text messages with guideline summaries, reminders of forthcoming appointments and/or arrangements for making new appointments in the event of non-attendance, and self-report cards to check compliance with recommendations. Both groups -intervention and control- will receive routine recommendations from their physicians in accordance with current European clinical practice guidelines for hypercholesterolaemia and cardiovascular risk management. As regards the measurements to be made, the main variable is the proportion of subjects who attain the low density lipoprotein cholesterol levels set as a target across a follow-up period of 24 months. The secondary variables are as follows: adherence to recommendations on lifestyle and adherence to drug treatment; variation in lipid profiles and cardiovascular risk levels; appearance of cardiovascular events; physical activity; food consumption; smoking habit; anthropometric measures; blood pressure; health problems; use of hypolipidaemic agents; socio-demographic data; beliefs and expectations about preventive recommendations; and degree of satisfaction with the combined strategy. DISCUSSION: Should this intervention prove effective, a recommendation could be issued on the application of this combined strategy to subjects with hypercholesterolaemia. It is a simple, relatively inexpensive intervention. TRIAL REGISTRATION: ClinicalTrials.gov: NCT02314663.
format Online
Article
Text
id pubmed-4361143
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43611432015-03-17 Effectiveness of a combined strategy to improve therapeutic compliance and degree of control among patients with hypercholesterolaemia: a randomised clinical trial Párraga-Martínez, Ignacio Rabanales-Sotos, Joseba Lago-Deibe, Fernando Téllez-Lapeira, Juan M Escobar-Rabadán, Francisco Villena-Ferrer, Alejandro Blasco-Valle, Mariano Ferreras-Amez, José M Morena-Rayo, Susana del Campo-del Campo, José M Ayuso-Raya, Maria Candelaria Pérez-Pascual, José J BMC Cardiovasc Disord Study Protocol BACKGROUND: In subjects with hypercholesterolaemia, cholesterol values remain above guideline levels. One of the limiting factors to the achievement of goals in such patients is therapeutic non-adherence. The aim of this study is to assess the effectiveness of an intervention designed to improve control of hypercholesterolaemic patients, consisting of a combined strategy that would include the delivery of printed information, treatment-compliance check cards and the dispatch of text messages as complementary measures in support of the intervention at the general practitioner’s practice. METHODS/DESIGN: A randomised, parallel-group clinical trial will be conducted at the family medicine outpatient facilities of eight health centres in three of Spain’s Autonomous Regions (Comunidades Autónomas), covering a total of 358 subjects aged 18 years or over with diagnosis of hypercholesterolaemia. Patients in the intervention group will be supplied with printed material with information on the disease and its management, mobile-telephone text messages with guideline summaries, reminders of forthcoming appointments and/or arrangements for making new appointments in the event of non-attendance, and self-report cards to check compliance with recommendations. Both groups -intervention and control- will receive routine recommendations from their physicians in accordance with current European clinical practice guidelines for hypercholesterolaemia and cardiovascular risk management. As regards the measurements to be made, the main variable is the proportion of subjects who attain the low density lipoprotein cholesterol levels set as a target across a follow-up period of 24 months. The secondary variables are as follows: adherence to recommendations on lifestyle and adherence to drug treatment; variation in lipid profiles and cardiovascular risk levels; appearance of cardiovascular events; physical activity; food consumption; smoking habit; anthropometric measures; blood pressure; health problems; use of hypolipidaemic agents; socio-demographic data; beliefs and expectations about preventive recommendations; and degree of satisfaction with the combined strategy. DISCUSSION: Should this intervention prove effective, a recommendation could be issued on the application of this combined strategy to subjects with hypercholesterolaemia. It is a simple, relatively inexpensive intervention. TRIAL REGISTRATION: ClinicalTrials.gov: NCT02314663. BioMed Central 2015-01-19 /pmc/articles/PMC4361143/ /pubmed/25599690 http://dx.doi.org/10.1186/1471-2261-15-8 Text en © Párraga-Martínez et al.; licensee BioMed Central. 2015 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Párraga-Martínez, Ignacio
Rabanales-Sotos, Joseba
Lago-Deibe, Fernando
Téllez-Lapeira, Juan M
Escobar-Rabadán, Francisco
Villena-Ferrer, Alejandro
Blasco-Valle, Mariano
Ferreras-Amez, José M
Morena-Rayo, Susana
del Campo-del Campo, José M
Ayuso-Raya, Maria Candelaria
Pérez-Pascual, José J
Effectiveness of a combined strategy to improve therapeutic compliance and degree of control among patients with hypercholesterolaemia: a randomised clinical trial
title Effectiveness of a combined strategy to improve therapeutic compliance and degree of control among patients with hypercholesterolaemia: a randomised clinical trial
title_full Effectiveness of a combined strategy to improve therapeutic compliance and degree of control among patients with hypercholesterolaemia: a randomised clinical trial
title_fullStr Effectiveness of a combined strategy to improve therapeutic compliance and degree of control among patients with hypercholesterolaemia: a randomised clinical trial
title_full_unstemmed Effectiveness of a combined strategy to improve therapeutic compliance and degree of control among patients with hypercholesterolaemia: a randomised clinical trial
title_short Effectiveness of a combined strategy to improve therapeutic compliance and degree of control among patients with hypercholesterolaemia: a randomised clinical trial
title_sort effectiveness of a combined strategy to improve therapeutic compliance and degree of control among patients with hypercholesterolaemia: a randomised clinical trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361143/
https://www.ncbi.nlm.nih.gov/pubmed/25599690
http://dx.doi.org/10.1186/1471-2261-15-8
work_keys_str_mv AT parragamartinezignacio effectivenessofacombinedstrategytoimprovetherapeuticcomplianceanddegreeofcontrolamongpatientswithhypercholesterolaemiaarandomisedclinicaltrial
AT rabanalessotosjoseba effectivenessofacombinedstrategytoimprovetherapeuticcomplianceanddegreeofcontrolamongpatientswithhypercholesterolaemiaarandomisedclinicaltrial
AT lagodeibefernando effectivenessofacombinedstrategytoimprovetherapeuticcomplianceanddegreeofcontrolamongpatientswithhypercholesterolaemiaarandomisedclinicaltrial
AT tellezlapeirajuanm effectivenessofacombinedstrategytoimprovetherapeuticcomplianceanddegreeofcontrolamongpatientswithhypercholesterolaemiaarandomisedclinicaltrial
AT escobarrabadanfrancisco effectivenessofacombinedstrategytoimprovetherapeuticcomplianceanddegreeofcontrolamongpatientswithhypercholesterolaemiaarandomisedclinicaltrial
AT villenaferreralejandro effectivenessofacombinedstrategytoimprovetherapeuticcomplianceanddegreeofcontrolamongpatientswithhypercholesterolaemiaarandomisedclinicaltrial
AT blascovallemariano effectivenessofacombinedstrategytoimprovetherapeuticcomplianceanddegreeofcontrolamongpatientswithhypercholesterolaemiaarandomisedclinicaltrial
AT ferrerasamezjosem effectivenessofacombinedstrategytoimprovetherapeuticcomplianceanddegreeofcontrolamongpatientswithhypercholesterolaemiaarandomisedclinicaltrial
AT morenarayosusana effectivenessofacombinedstrategytoimprovetherapeuticcomplianceanddegreeofcontrolamongpatientswithhypercholesterolaemiaarandomisedclinicaltrial
AT delcampodelcampojosem effectivenessofacombinedstrategytoimprovetherapeuticcomplianceanddegreeofcontrolamongpatientswithhypercholesterolaemiaarandomisedclinicaltrial
AT ayusorayamariacandelaria effectivenessofacombinedstrategytoimprovetherapeuticcomplianceanddegreeofcontrolamongpatientswithhypercholesterolaemiaarandomisedclinicaltrial
AT perezpascualjosej effectivenessofacombinedstrategytoimprovetherapeuticcomplianceanddegreeofcontrolamongpatientswithhypercholesterolaemiaarandomisedclinicaltrial